Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 11-2023 | 08-2023 | 05-2023 | 02-2023 | 11-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,064 | 345 | 1,256 | 30 | 820 |
| Receivables | 48 | 29 | 23 | 15 | 7 |
| Other current assets | 32 | 53 | 78 | 92 | 91 |
| TOTAL | $2,181 | $482 | $1,453 | $338 | $1,098 |
| Non-Current Assets | |||||
| Intangibles | 171 | 171 | 171 | 163 | 163 |
| TOTAL | $171 | $171 | $171 | $163 | $163 |
| Total Assets | $2,353 | $653 | $1,624 | $501 | $1,261 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,013 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,925 | 1,881 | 1,840 | 1,917 | 1,510 |
| TOTAL | $6,969 | $1,971 | $1,840 | $1,987 | $1,567 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 2,103 | 1,229 | N/A | N/A |
| Other Non-Current Liabilities | 276 | 339 | 564 | 0 | 0 |
| TOTAL | $276 | $2,442 | $1,794 | $0 | $0 |
| Total Liabilities | $7,245 | $4,413 | $3,633 | $1,987 | $1,567 |
| Shareholders' Equity | |||||
| Common Shares | 13,497 | 13,497 | 13,497 | 13,497 | 13,497 |
| Retained earnings | -22,600 | -21,439 | -19,749 | -19,093 | -17,807 |
| Other shareholders' equity | 655 | 655 | 734 | 655 | 655 |
| TOTAL | $-4,893 | $-3,760 | $-2,009 | $-1,486 | $-305 |
| Total Liabilities And Equity | $2,353 | $653 | $1,624 | $501 | $1,261 |